|
1
|
Cohen PA, Jhingran A, Oaknin A and Denny
L: Cervical cancer. Lancet. 393:169–182. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dickinson JA: Age of initiation of
cervical cancer screening. JAMA. 321:611–612. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Petrelli F, De Stefani A, Raspagliesi F,
Lorusso D and Barni S: Radiotherapy with concurrent cisplatin-based
doublet or weekly cisplatin for cervical cancer: A systematic
review and meta-analysis. Gynecol Oncol. 134:166–171. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Global Burden of Disease Cancer
Collaboration, ; Fitzmaurice C, Dicker D, Pain A, Hamavid H,
Moradi-Lakeh M, MacIntyre MF, Allen C, Hansen G, Woodbrook R, et
al: The Global Burden of Cancer 2013. JAMA Oncol. 1:505–527. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Begg AC, Stewart FA and Vens C: Strategies
to improve radiotherapy with targeted drugs. Nat Rev Cancer.
11:239–253. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang W, Zhang F, Hu K and Hou X:
Image-guided, intensity-modulated radiation therapy in definitive
radiotherapy for 1,433 patients with cervical cancer. Gynecol
Oncol. 151:444–448. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ishikawa K, Koyama-Saegusa K, Otsuka Y,
Ishikawa A, Kawai S, Yasuda K, Suga T, Michikawa Y, Suzuki M,
Iwakawa M and Imai T: Gene expression profile changes correlating
with radioresistance in human cell lines. Int J Radiat Oncol Biol
Phys. 65:234–245. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Theys J, Jutten B, Habets R, Paesmans K,
Groot AJ, Lambin P, Wouters BG, Lammering G and Vooijs M:
E-Cadherin loss associated with EMT promotes radioresistance in
human tumor cells. Radiother Oncol. 99:392–397. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Carlson DJ, Yenice KM and Orton CG: Tumor
hypoxia is an important mechanism of radioresistance in
hypofractionated radiotherapy and must be considered in the
treatment planning process. Med Phys. 38:6347–6350. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Grana TM, Rusyn EV, Zhou H, Sartor CI and
Cox AD: Ras mediates radioresistance through both
phosphatidylinositol 3-kinase-dependent and Raf-dependent but
mitogen-activated protein kinase/extracellular signal-regulated
kinase kinase-independent signaling pathways. Cancer Res.
62:4142–4150. 2002.PubMed/NCBI
|
|
11
|
Skvortsova I, Skvortsov S, Stasyk T, Raju
U, Popper BA, Schiestl B, von Guggenberg E, Neher A, Bonn GK, Huber
LA and Lukas P: Intracellular signaling pathways regulating
radioresistance of human prostate carcinoma cells. Proteomics.
8:4521–4533. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bristow RG and Hill RP: Hypoxia and
metabolism. Hypoxia, DNA repair and genetic instability. Nat Rev
Cancer. 8:180–192. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fabbrizi MR, Warshowsky KE, Zobel CL,
Hallahan DE and Sharma GG: Molecular and epigenetic regulatory
mechanisms of normal stem cell radiosensitivity. Cell Death Discov.
18:4:1172018. View Article : Google Scholar
|
|
14
|
Wei W, Dong Z, Gao H, Zhang YY, Shao LH,
Jin LL, Lv YH, Zhao G, Shen YN and Jin SZ: MicroRNA-9 enhanced
radiosensitivity and its mechanism of DNA methylation in non-small
cell lung cancer. Gene. 710:178–185. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sutton LP, Jeffreys SA, Phillips JL,
Taberlay PC, Holloway AF, Ambrose M, Joo JE, Young A, Berry R,
Skala M and Brettingham-Moore KH: DNA methylation changes following
DNA damage in prostate cancer cells. Epigenetics. 14:989–1002.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hervouet E, Cheray M, Vallette FM and
Cartron PF: DNA methylation and apoptosis resistance in cancer
cells. Cells. 2:545–573. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Desjobert C, El Maï M, Gérard-Hirne T,
Guianvarc'h D, Carrier A, Pottier C, Arimondo PB and Riond J:
Combined analysis of DNA methylation and cell cycle in cancer
cells. Epigenetics. 10:82–91. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pfeifer GP: Defining driver DNA
methylation changes in human cancer. Int J Mol Sci. 19:11662018.
View Article : Google Scholar
|
|
19
|
Russo G, Landi R, Pezone A, Morano A,
Zuchegna C, Romano A, Muller MT, Gottesman ME, Porcellini A and
Avvedimento EV: DNA damage and repair modify DNA methylation and
chromatin domain of the targeted locus: Mechanism of allele
methylation polymorphism. Sci Rep. 6:332222016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Borràs-Fresneda M, Barquinero JF, Gomolka
M, Hornhardt S, Rössler U, Armengol G and Barrios L: Differences in
DNA repair capacity, cell death and transcriptional response after
irradiation between a radiosensitive and a radioresistant cell
line. Sci Rep. 6:270432016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dukaew N, Konishi T, Chairatvit K,
Autsavapromporn N, Soonthornchareonnon N and Wongnoppavich A:
Enhancement of radiosensitivity by eurycomalactone in human NSCLC
cells through G2/M cell cycle arrest and delayed DNA
double-strand break repair. Oncol Res. 28:161–175. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Feng Q, Hawes SE, Stern JE, Dem A, Sow PS,
Dembele B, Toure P, Sova P, Laird PW and Kiviat NB: Promoter
hypermethylation of tumor suppressor genes in urine from patients
with cervical neoplasia. Cancer Epidemiol Biomarkers Prev.
16:1178–1184. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Snoek BC, Splunter APV, Bleeker MCG,
Ruiten MCV, Heideman DAM, Rurup WF, Verlaat W, Schotman H, Gent MV,
Trommel NEV and Steenbergen RDM: Cervical cancer detection by DNA
methylation analysis in urine. Sci Rep. 9:30882019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kazim N, Adhikari A, Oh TJ and Davie J:
The transcription elongation factor TCEA3 induces apoptosis in
rhabdomyosarcoma. Cell Death Dis. 11:672020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chi HC, Tsai CY, Tsai MM and Lin KH:
Impact of DNA and RNA methylation on radiobiology and cancer
progression. Int J Mol Sci. 19:5552018. View Article : Google Scholar
|
|
26
|
Jiao X, Zhang S, Jiao J, Zhang T, Qu W,
Muloye GM, Kong B, Zhang Q and Cui B: Promoter methylation of SEPT9
as a potential biomarker for early detection of cervical cancer and
its overexpression predicts radioresistance. Clin Epigenetics.
11:1202019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Guerrero-Setas D, Pérez-Janices N,
Blanco-Fernandez L, Ojer A, Cambra K, Berdasco M, Esteller M,
Maria-Ruiz S, Torrea N and Guarch R: LRASSF hypermethylation is
present and related to shorter survival in squamous cervical
cancer. Mod Pathol. 26:1111–1122. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zerbini LF and Libermann TA: GADD45
deregulation in cancer: Frequently methylated tumor suppressors and
potential therapeutic targets. Clin Cancer Res. 11:6409–6413. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ying J, Srivastava G, Hsieh WS, Gao Z,
Murray P, Liao SK, Ambinder R and Tao Q: The stress-responsive gene
GADD45G is a functional tumor suppressor, with its response to
environmental stresses frequently disrupted epigenetically in
multiple tumors. Clin Cancer Res. 11:6442–6449. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zackrisson B: Radiobiological cell
survival models. A methodological overview. Acta Oncol. 31:433–441.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Na YK, Lee SM, Hong HS, Kim JB, Park JY
and Kim DS: Hypermethylation of growth arrest DNA-damage-inducible
gene 45 in non-small cell lung cancer and its relationship with
clinicopathologic features. Mol Cells. 30:89–92. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tsikouras P, Zervoudis S, Manav B, Tomara
E, Iatrakis G, Romanidis C, Bothou A and Galazios G: Cervical
cancer: Screening, diagnosis and staging. J BUON. 21:320–325.
2016.PubMed/NCBI
|
|
34
|
Egger G, Liang G, Aparicio A and Jones PA:
Epigenetics in human disease and prospects for epigenetic therapy.
Nature. 429:457–463. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang W, Li T, Shao Y, Zhang C, Wu Q, Yang
H, Zhang J, Guan M, Yu B and Wan J: Semi-quantitative detection of
GADD45-gamma methylation levels in gastric, colorectal and
pancreatic cancers using methylation-sensitive high-resolution
melting analysis. J Cancer Res Clin Oncol. 136:1267–1273. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kim JS, Kim SY, Lee M, Kim SH, Kim SM and
Kim EJ: Radioresistance in a human laryngeal squamous cell
carcinoma cell line is associated with DNA methylation changes and
topoisomerase II α. Cancer Biol Ther. 16:558–566. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Smits KM, Melotte V, Niessen HE, Dubois L,
Oberije C, Troost EG, Starmans MH, Boutros PC, Vooijs M, van
Engeland M and Lambin P: Epigenetics in radiotherapy: Where are we
heading? Radiother Oncol. 111:168–177. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Dote H, Cerna D, Burgan WE, Carter DJ,
Cerra MA, Hollingshead MG, Camphausen K and Tofilon PJ: Enhancement
of in vitro and in vivo tumor cell radiosensitivity by the DNA
methylation inhibitor zebularine. Clin Cancer Res. 11:4571–4579.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kim EH, Park AK, Dong SM, Ahn JH and Park
WY: Global analysis of CpG methylation reveals epigenetic control
of the radiosensitivity in lung cancer cell lines. Oncogene.
29:4725–4731. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Muschel RJ, Soto DE, McKenna WG and
Bernhard EJ: Radiosensitization and apoptosis. Oncogene.
17:3359–3363. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yuan YH, Wang HY, Lai Y, Zhong W, Liang
WL, Yan FD, Yu Z, Chen JK and Lin Y: Epigenetic inactivation of
HOXD10 is associated with human colon cancer via inhibiting the
RHOC/AKT/MAPK signaling pathway. Cell Commun Signal. 17:92019.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Schuurbiers OC, Kaanders JH, van der
Heijden HF, Dekhuijzen RP, Oyen WJ and Bussink J: The
PI3-K/AKT-pathway and radiation resistance mechanisms in non-small
cell lung cancer. J Thorac Oncol. 4:761–767. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhou HM, Sun QX and Cheng Y: Paeonol
enhances the sensitivity of human ovarian cancer cells to
radiotherapy-induced apoptosis due to downregulation of the
phosphatidylinositol-3-kinase/Akt/phosphatase and tensin homolog
pathway and inhibition of vascular endothelial growth factor. Exp
Ther Med. 14:3213–3220. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Man J, Shoemake JD, Ma T, Rizzo AE, Godley
AR, Wu Q, Mohammadi AM, Bao S, Rich JN and Yu JS: Hyperthermia
sensitizes glioma stem-like cells to radiation by inhibiting AKT
signaling. Cancer Res. 75:1760–1769. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Otani K, Naito Y, Sakaguchi Y, Seo Y,
Takahashi Y, Kikuta J, Ogawa K and Ishii M: Cell-cycle-controlled
radiation therapy was effective for treating a murine malignant
melanoma cell line in vitro and in vivo. Sci Rep. 6:306892016.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kim JG, Bae JH, Kim JA, Heo K, Yang K and
Yi JM: Combination effect of epigenetic regulation and ionizing
radiation in colorectal cancer cells. PLoS One. 9:e1054052014.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Jiang W, Li YQ, Liu N, Sun Y, He QM, Jiang
N, Xu YF, Chen L and Ma J: 5-Azacytidine enhances the
radiosensitivity of CNE2 and SUNE1 cells in vitro and in vivo
possibly by altering DNA methylation. PLoS One. 9:e932732014.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Momparler RL: Epigenetic therapy of
non-small cell lung cancer using decitabine
(5-aza-2′-deoxycytidine). Front Oncol. 3:1882013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Kim HJ, Kim JH, Chie EK, Young PD, Kim IA
and Kim IH: DNMT (DNA methyltransferase) inhibitors radiosensitize
human cancer cells by suppressing DNA repair activity. Radiat
Oncol. 7:392012. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Wang L, Zhang Y, Li R, Chen Y, Pan X, Li
G, Dai F and Yang J: 5-aza-2′-Deoxycytidine enhances the
radiosensitivity of breast cancer cells. Cancer Biother Radiopharm.
28:34–44. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Steiner M, Clark B, Tang JZ, Zhu T and
Lobie PE: 14-3-3σ mediates G2-M arrest produced by
5-aza-2′-deoxycytidine and possesses a tumor suppressor role in
endometrial carcinoma cells. Gynecol Oncol. 127:231–240. 2012.
View Article : Google Scholar : PubMed/NCBI
|
